Method of balancing a patient's canabinoid metabolite ratio

Abstract

The invention provides a method and a structure for balancing cannabinoid metabolites within a patient. Using a stool sample, a panel of cannabinoid metabolite levels is established and compared to ideal ranges thereof. Metabolites outside of the ideal range are treated with a cannabis product or alternatively with traditional medicines.

Claims

1. A medical treatment system comprising: a) a laboratory, using a patient's stool sample having: (1) a diagnostic mechanism adapted to generate an indicia for cannabinoids from an analysis of the patient's stool sample, and, (2) a computer system adapted to, a) compare the indicia to a database of ideal values to obtain a comparison reference, and, b) identify a particular cannabis product in response to the comparison reference, and b) a dispensary, communicating with the computer system of the laboratory, to provide the particular cannabis product based on the comparison reference to the patient.

2. The medical treatment system according to claim 1, wherein the diagnostic mechanism is responsive to cannabinoid metabolites.

3. The medical treatment system according to claim 2, wherein the dispensary provides a non-cannabis treatment with the particular cannabis product.

4. The medical treatment system according to claim 1, further including a delivery service for delivery of the particular cannabis from the dispensary to the patient.

5. The medical treatment system according to claim 4, further including a postal system for delivery of the patient's stool sample to the laboratory.

6. The medical treatment system according to claim 5, wherein the laboratory further includes a communication center adapted to communicate the comparison reference and the particular cannabis product to the patient.

7. A medical treatment system for a patient's cannabinoid metabolite levels comprising: a) a laboratory, using a patient's stool sample having, 1) using the patient's stool sample, a diagnostic mechanism adapted to generate a metabolite indicia for cannabinoid metabolites of a selected cannabinoid, and, 2) a computer system adapted to, A) compare the metabolite indicia to a database of ideal values for the cannabinoid metabolite to obtain a comparison reference, and, B) identify a particular cannabis product in response to the comparison reference, said particular cannabis product selected to adjust the patient's cannabinoid metabolite level towards the ideal level; and, b) a dispensary, communicating with the computer system of the laboratory, to provide the particular cannabis product for the patient; and, c) a delivery mechanism transporting the particular cannabis product from the dispensary to a residence of the patient.

8. The medical treatment system according to claim 7, wherein the dispensary provides a non-cannabis treatment with the particular cannabis product.

9. The medical treatment system according to claim 7, further including a postal system for delivery of the patient's stool sample to the laboratory.

10. A laboratory comprising: a) a diagnostic mechanism adapted to generate a metabolite indicia for cannabinoid metabolites from an analysis of a patient's stool sample; and, b) a computer system adapted to, 1) compare the metabolite indicia to a database of ideal values of cannaboid metabolites to obtain a comparison reference, 2) based upon the comparison reference, identify a particular cannabis product, and 3) communicate the patient's name and the particular cannabis product to a dispensary for distribution to the patient.

Description

DRAWINGS IN BRIEF

[0018] FIG. 1 is a diagram illustrating the transfer of physical elements together with data transfer found in the preferred embodiment of the invention.

DRAWINGS IN DETAIL

[0019] FIG. 1 is a diagram illustrating the transfer of physical elements together with data transfer found in the preferred embodiment of the invention. In this illustration the stool sample is obtained by the patient at their home 10. The invention is not so limited as the place of the collection of the sample, and includes a variety of locations obvious to those of ordinary skill in the art, including, but not limited to: a physician's office, a hospital, a clinic, and a marijuana dispensary.

[0020] The sample is communicated 16a (ideally by mail) to a laboratory 11 where the metabolites for cannabinoids are established and communicated 16B to a computer 12A where the metabolite levels are collected and correlated. Note, in some embodiments, this includes terpenes and other cannabis molecules. This information is cross referenced to current scientific research results,

[0021] In the preferred embodiment, this metabolite test includes a metabolite of Cannabidiol and in some embodiments terpenes.

[0022] In the preferred embodiment, computer 12A also collects data from other sources dealing with not only which cannabinoid metabolites are important, but also commentary from other patients together with results from scientific research.

[0023] The cannabinoid metabolite data is analyzed to determine the data's position within a range (within an ideal range or outside the ideal range as stored with computer 12A). The results of the analysis, together with recommended treatment for those metabolites outside of the ideal range, is communicated 16C to printer or other communication apparatus 12B.

[0024] In the preferred embodiment, the analysis with recommendations, is communicated 16D to care giver 13 who uses this information to prescribe a cannabis treatment 16E to marijuana dispensary 14. Using the prescription from the care giver 13, marijuana dispensary 14 delivers 16F the prescribed cannabis treatment to the patient's house 10. In an alternative embodiment, the patient retrieves the cannabis treatment from the dispensary after providing proper proof of their identity.

[0025] In some situations, a non-cannabis treated is warranted. In that case, the care-giver communicates the non-cannabis prescription 17C to a traditional pharmacy 15 where the prescription is either delivered 17D to the patient's home or is retrieved from the pharmacy 15 by the patient.

[0026] In yet another embodiment, the analysis is communicated 17B from the communication apparatus to the dispensary 14; a message is also communicated 17A to the patient's house that the dispensary 14 has the report and to retrieve the appropriate treatment.

[0027] It is clear that the present invention provides a method and structure for the proper diagnosis and treatment of cannabis conditions within the human body.